Park Medi World LimitedPARKHOSPSCorporate

Hospital Latest results: Jun 2026 6 quarters of data
₹235.70
MCap ₹10,181 Cr · P/E 34.2
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹476 Cr
Sales · Jun 2026
+19.3% YoY
₹126 Cr
Operating Profit · Jun 2026
+20.0% YoY
26.5%
OPM % · Jun 2026
+0.8% YoY
₹89 Cr
Net Profit · Jun 2026
+34.8% YoY
₹1.91
EPS · Jun 2026
+26.5% YoY

📝 Park Medi World Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Park Medi World Limited reported revenue of ₹476 crore for the quarter ended June 2026 (Q1 FY27), up 19.3% from ₹399 crore in the same quarter last year, and up 3.4% sequentially over the March 2026 quarter.

Net profit rose 34.8% year-on-year to ₹89 crore, from ₹66 crore. Earnings per share (EPS) came in at ₹1.91.

Operating profit stood at ₹126 crore — an operating margin (OPM) of 26.5%, compared with 26.3% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Park Medi World Limited posted revenue of ₹1,679 crore, with a net profit of ₹275 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹1,756 crore with a net profit of ₹298 crore.

Valuation snapshot

At the current price of ₹235.70, PARKHOSPS has a market capitalisation of ₹10,181 crore and a trailing P/E of about 34.2.

Within the Hospital industry, it is the largest of the 10 companies we track by market value.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹10,181 Cr
Current Price ?
₹235.7
P/E ?
34.21below ind
Industry P/E ?
39.60
P/B ?
N/A
P/S ?
5.80
P/FCF ?
N/A
Enterprise Value ?
N/A
EV/EBITDA ?
N/A
PEG ?
N/A
Earnings Yield ?
2.9%
Dividend Yield ?
N/A
Profitability & Returns
Sales (TTM) ?
₹1,756 Cr
OPM ?
26.5%
Profit after tax (TTM) ?
₹298 Cr
EPS (TTM) ?
₹6.89
ROCE ?
N/A
ROE ?
N/A
ROA ?
N/A
Growth
Sales — latest qtr ?
₹476 Cr
PAT — latest qtr ?
₹89 Cr
YoY qtr sales growth ?
19.3%
YoY qtr profit growth ?
34.8%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
N/A
Profit growth (3y) ?
N/A
Profit growth (5y) ?
N/A
Financial Health
Debt ?
N/A
Debt to Equity ?
N/A
Interest Coverage ?
6.5
Current Ratio ?
N/A
Ownership
Promoter holding ?
N/A
Change in promoter holding ?
N/A
Pledged percentage ?
N/A
Market
Return 3 months ?
-14.0%
Return 6 months ?
8.9%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 354399410410460476 +19.3% +3.4%
Operating Profit 8810511399127126 +20.0% -1.1%
Other Income 978988 +14.3% +6.6%
Interest 161515151410 -33.3% -28.4%
Depreciation 161515151819 +26.7% +8.5%
Profit Before Tax 66829178103105 +28.0% +1.6%
Net Profit 526679537789 +34.8% +15.9%
EPS 1.171.511.911.351.781.91 +26.5% +7.3%
OPM % 24.9% 26.3% 27.6% 24.2% 27.7% 26.5% +0.8% -4.3%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric Prev FY FY26 TTM YoY %
Sales — ₹1,679 Cr ₹1,756 Cr —
Operating Profit — ₹445 Cr ₹466 Cr —
OPM % — 26.48% 26.52% —
NPM % — 16.35% 16.95% —
Other Income — ₹32 Cr ₹33 Cr —
Depreciation — ₹63 Cr ₹67 Cr —
Interest — ₹59 Cr ₹54 Cr —
EBIT — ₹382 Cr ₹399 Cr —
PBT — ₹355 Cr ₹378 Cr —
Tax — ₹52 Cr ₹52 Cr —
Net Profit — ₹275 Cr ₹298 Cr —
EPS — ₹6.55 ₹6.95 —
Material Cost — ₹154 Cr ₹154 Cr —
Employee Cost — ₹169 Cr ₹169 Cr —
Extraordinary Items — — — —

⚖️ Peer comparison

Industry: Hospital · 10 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 PARKHOSPS Park Medi ₹280.90 12,133 42.4 1,756 298 26.5% 16.9% — — 19.3% 34.8%
2 526783 Dr Agarwals ₹5,253.00 2,465 33.3 497 75 30.4% 15.2% 18.6% 27.8% 22.2% 37.5%
3 524520 KMC Speciality ₹81.32 2,373 23.8 331 57 30.4% 17.1% 32.5% 108.7% 37.0% 107.2%
4 GKSL Gujarat Kidney ₹172.33 1,359 — — — — — — — — —
5 543346 Aashka Hospitals ₹117.80 195 83.0 23 3 22.8% 14.5% — — 22.3% 55.2%
6 531658 Abate As ₹28.64 120 266.9 — 2 — — — 158.6% — 10.1%
7 523696 Fortis Malar ₹65.66 79 n/m 0 0 -5165.0% 427.8% — 932.5% -95.5% -96.3%
8 544013 KK Shah ₹49.79 30 — 9 -1 8.2% -6.6% — — -7.2% 57.1%
9 539378 Soni Medicare ₹26.49 30 — 23 -4 -8.1% -15.5% -15.9% -1405.6% -39.2% -313.3%
10 543520 Global Longlife ₹30.99 16 — — -2 — — — — — 61.5%
❓ Frequently asked questions
What was Park Medi World Limited's revenue in Q1 FY27?
Park Medi World Limited reported revenue of ₹476 crore for the quarter ended June 2026 (Q1 FY27), up 19.3% from ₹399 crore in the same quarter last year, and up 3.4% sequentially over the March 2026 quarter.
What was Park Medi World Limited's net profit in Q1 FY27?
Net profit rose 34.8% year-on-year to ₹89 crore, from ₹66 crore. Earnings per share (EPS) came in at ₹1.91.
What is PARKHOSPS's market capitalisation and P/E ratio?
At the current price of ₹235.70, PARKHOSPS has a market capitalisation of ₹10,181 crore and a trailing P/E of about 34.2.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI